Article
Emergence of NNRTI drug resistance mutations after single-dose nevirapine exposure in HIV type 1 subtype C-infected infants in India.
AIDS research and human retroviruses - 1 May 2007
Kurle Swarali N, Gangakhedkar Raman R, Sen Sourav, Hayatnagarkar Shilpa S, Tripathy Srikanth P, Paranjape Ramesh S
Abstract excerpt
A feasibility study for providing single-dose nevirapine (SD-NVP) prophylaxis for prevention of mother-to-child transmission (PMTCT) of HIV infection provided an opportunity to study the emergence of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance mutations as a result of single-...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
